| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Prostate cancer is the most common cancer in men, and treatment can often permanently change not only the patient's life, but also the lives of their loved ones. At Medlogical Innovations, our mission is to drive better outcomes in prostate cancer management with precision-engineered and purpose-designed technology. By minimising side effects, we're empowering men to lead a normal and full life afterwards. The ProFocal¬Æ System delivers Cooled Laser Focal Therapy ‚ a minimally invasive, outpatient treatment for prostate cancer. As an alternative to whole-gland treatments which often result in debilitating side effects, the ProFocal System is designed to accurately target and ablate specific areas, safely avoiding the delicate nerves and tissues surrounding the prostate. |
| Category: | Health & biotech |
| URL: | https://www.medlogicalinnovations.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2017 |
| Address: | 3 Apollo Place, Suite G01, Lane Cove West, NSW 2066, AU |
| State: | New South Wales |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/medlogical-innovations |
| Founders: |
No items found
|
| Awards won: | |
